| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3133070 | Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient | GENZYME CORPORATION | May 14, 2020 |
Feel free to send us a message here and we will get back to you